• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KCNQ 编码钾通道作为治疗靶点。

KCNQ-Encoded Potassium Channels as Therapeutic Targets.

机构信息

Vascular Biology Research Centre, Molecular and Clinical Sciences Institute, St George's, University of London, London, SW17 0RE, United Kingdom; email:

出版信息

Annu Rev Pharmacol Toxicol. 2018 Jan 6;58:625-648. doi: 10.1146/annurev-pharmtox-010617-052912. Epub 2017 Oct 6.

DOI:10.1146/annurev-pharmtox-010617-052912
PMID:28992433
Abstract

K7 channels are voltage-gated potassium channels encoded by KCNQ genes that have a considerable physiological impact in many cell types. This reliance upon K7 channels for normal cellular function, as well as the existence of hereditary disorders caused by mutations to KCNQ genes, means that pharmacological targeting of these channels has broad appeal. Consequently, a plethora of chemical entities that modulate K7 channel activity have been developed. Moreover, K7 channels are influenced by many disparate intracellular mediators and trafficking processes, making upstream targeting an appealing prospect for therapeutic development. This review covers the main characteristics of these multifunctional and versatile channels with the aim of providing insight into the therapeutic value of targeting these channels.

摘要

K7 通道是由 KCNQ 基因编码的电压门控钾通道,在许多细胞类型中具有重要的生理影响。这种对 K7 通道正常细胞功能的依赖,以及由 KCNQ 基因突变引起的遗传性疾病的存在,意味着这些通道的药理学靶向具有广泛的吸引力。因此,已经开发出了大量调节 K7 通道活性的化学实体。此外,K7 通道受到许多不同的细胞内介质和运输过程的影响,使得上游靶向成为治疗开发的一个有吸引力的前景。本综述涵盖了这些多功能和通用通道的主要特征,旨在为靶向这些通道的治疗价值提供深入了解。

相似文献

1
KCNQ-Encoded Potassium Channels as Therapeutic Targets.KCNQ 编码钾通道作为治疗靶点。
Annu Rev Pharmacol Toxicol. 2018 Jan 6;58:625-648. doi: 10.1146/annurev-pharmtox-010617-052912. Epub 2017 Oct 6.
2
K7 channels in the human detrusor: channel modulator effects and gene and protein expression.人逼尿肌中的K7通道:通道调节剂作用以及基因与蛋白表达
Naunyn Schmiedebergs Arch Pharmacol. 2017 Feb;390(2):127-137. doi: 10.1007/s00210-016-1312-9. Epub 2016 Oct 19.
3
Novel treatment strategies for smooth muscle disorders: Targeting Kv7 potassium channels.平滑肌疾病的新型治疗策略:靶向 Kv7 钾通道。
Pharmacol Ther. 2016 Sep;165:14-25. doi: 10.1016/j.pharmthera.2016.05.002. Epub 2016 May 11.
4
Expression and motor functional roles of voltage-dependent type 7 K(+) channels in the human taenia coli.电压依赖性 7 型 K(+) 通道在人结肠带中的表达和运动功能作用。
Eur J Pharmacol. 2013 Dec 5;721(1-3):12-20. doi: 10.1016/j.ejphar.2013.09.061. Epub 2013 Oct 10.
5
The expression and function of KCNQ potassium channels in human chorionic plate arteries from women with normal pregnancies and pre-eclampsia.正常妊娠和子痫前期妇女胎盘动脉中 KCNQ 钾通道的表达和功能。
PLoS One. 2018 Mar 26;13(3):e0192122. doi: 10.1371/journal.pone.0192122. eCollection 2018.
6
KV7 channelopathies.KV7 通道病。
Pflugers Arch. 2010 Jul;460(2):277-88. doi: 10.1007/s00424-010-0831-3. Epub 2010 Apr 18.
7
Vascular Kv7 channels control intracellular Ca dynamics in smooth muscle.血管 Kv7 通道控制平滑肌细胞内的 Ca 动力学。
Cell Calcium. 2020 Dec;92:102283. doi: 10.1016/j.ceca.2020.102283. Epub 2020 Aug 29.
8
Bimodal effects of the Kv7 channel activator retigabine on vascular K+ currents.Kv7通道激活剂瑞替加滨对血管钾离子电流的双峰效应。
Br J Pharmacol. 2008 Sep;155(1):62-72. doi: 10.1038/bjp.2008.231. Epub 2008 Jun 9.
9
Ligand modulation of KCNQ-encoded (K7) potassium channels in the heart and nervous system.心脏和神经系统中 KCNQ 编码(K7)钾通道的配体调节。
Eur J Pharmacol. 2021 Sep 5;906:174278. doi: 10.1016/j.ejphar.2021.174278. Epub 2021 Jun 24.
10
New tricks for old dogs: KCNQ expression and role in smooth muscle.老狗也有新把戏:KCNQ 表达及其在平滑肌中的作用。
Br J Pharmacol. 2009 Apr;156(8):1196-203. doi: 10.1111/j.1476-5381.2009.00131.x.

引用本文的文献

1
(+)-Borneol Enhances the Antiseizure Effects of Retigabine by both Pharmacokinetic and Pharmacodynamic Interaction.(+)-冰片通过药代动力学和药效学相互作用增强瑞替加滨的抗癫痫作用。
Neurochem Res. 2025 Apr 19;50(3):147. doi: 10.1007/s11064-025-04396-w.
2
Interim analysis of the long-term efficacy and safety of azetukalner in an ongoing open-label extension study following a phase 2b clinical trial (X-TOLE) in adults with focal epilepsy.在一项针对局灶性癫痫成人患者的2b期临床试验(X-TOLE)之后正在进行的开放标签扩展研究中,对阿泽卡奈的长期疗效和安全性进行的中期分析。
Epilepsia Open. 2025 Apr;10(2):539-548. doi: 10.1002/epi4.70015. Epub 2025 Mar 7.
3
Targeting Kv7 Potassium Channels for Epilepsy.
靶向Kv7钾通道治疗癫痫
CNS Drugs. 2025 Mar;39(3):263-288. doi: 10.1007/s40263-024-01155-3. Epub 2025 Jan 24.
4
Pimozide Inhibits Type II but Not Type I Hair Cells in Chicken Embryo and Adult Mouse Vestibular Organs.匹莫齐特抑制鸡胚和成年小鼠前庭器官中的II型毛细胞,但不抑制I型毛细胞。
Biomedicines. 2024 Dec 18;12(12):2879. doi: 10.3390/biomedicines12122879.
5
Secretase promotes AD progression: simultaneously cleave Notch and APP.分泌酶促进阿尔茨海默病进展:同时切割Notch和淀粉样前体蛋白(APP)。
Front Aging Neurosci. 2024 Nov 20;16:1445470. doi: 10.3389/fnagi.2024.1445470. eCollection 2024.
6
Constitutive opening of the Kv7.2 pore activation gate causes -developmental encephalopathy.Kv7.2 孔激活门的组成型开放导致发育性脑病。
Proc Natl Acad Sci U S A. 2024 Dec 3;121(49):e2412388121. doi: 10.1073/pnas.2412388121. Epub 2024 Nov 27.
7
Potassium channels in depression: emerging roles and potential targets.抑郁症中的钾通道:新出现的作用和潜在靶点。
Cell Biosci. 2024 Nov 11;14(1):136. doi: 10.1186/s13578-024-01319-0.
8
Crucial role for sensory nerves and Na/H exchanger inhibition in dapagliflozin- and empagliflozin-induced arterial relaxation.利拉鲁肽和艾塞那肽对心血管系统的影响。
Cardiovasc Res. 2024 Nov 25;120(14):1811-1824. doi: 10.1093/cvr/cvae156.
9
GRT-X Stimulates Dorsal Root Ganglia Axonal Growth in Culture via TSPO and Kv7.2/3 Potassium Channel Activation.GRT-X 通过 TSPO 和 Kv7.2/3 钾通道激活促进培养中的背根神经节轴突生长。
Int J Mol Sci. 2024 Jul 3;25(13):7327. doi: 10.3390/ijms25137327.
10
Identification of common genetic variants in family genes associated with gastric cancer survival in a Chinese population.中国人群中与胃癌生存相关家族基因常见遗传变异的鉴定。
J Biomed Res. 2024 May 29;39(1):76-86. doi: 10.7555/JBR.38.20240040.